Hochschulschrift
Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Deutsch
- Anmerkungen
-
Marburg, Univ., Diss., 2006
- Schlagwort
-
OPG ; RANKL ; Schilddrüse ; Schilddrüsenkarzinom
Krebs
Onkologie
- Urheber
- URN
-
urn:nbn:de:hebis:04-z2006-06929
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort
Charakterisierung von Osteoprotegerin (OPG) und receptor activator of NF-κB-ligand [NF-kappa-B-ligand] (RANKL) in der Schilddrüse
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Auswirkung von Bisphosphonaten auf die Expression von Osteoprotegerin (OPG) und Receptor activator of nuclear factor kappa-B ligand (RANKL) in Osteoblastenkulturen aus Unterkiefer und Becken : eine Pilotstudie am Hausschwein
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
RANK/RANKL/OPG system in the intervertebral disc
PI and OPG/RANKL levels in human osteoblast cells
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
Mechanical force regulates root resorption in rats through RANKL and OPG
Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients
Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort
Charakterisierung von Osteoprotegerin (OPG) und receptor activator of NF-κB-ligand [NF-kappa-B-ligand] (RANKL) in der Schilddrüse
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Auswirkung von Bisphosphonaten auf die Expression von Osteoprotegerin (OPG) und Receptor activator of nuclear factor kappa-B ligand (RANKL) in Osteoblastenkulturen aus Unterkiefer und Becken : eine Pilotstudie am Hausschwein
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
RANK/RANKL/OPG system in the intervertebral disc
PI and OPG/RANKL levels in human osteoblast cells
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
Mechanical force regulates root resorption in rats through RANKL and OPG
Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients
Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort
Charakterisierung von Osteoprotegerin (OPG) und receptor activator of NF-κB-ligand [NF-kappa-B-ligand] (RANKL) in der Schilddrüse
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Auswirkung von Bisphosphonaten auf die Expression von Osteoprotegerin (OPG) und Receptor activator of nuclear factor kappa-B ligand (RANKL) in Osteoblastenkulturen aus Unterkiefer und Becken : eine Pilotstudie am Hausschwein
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
RANK/RANKL/OPG system in the intervertebral disc
PI and OPG/RANKL levels in human osteoblast cells
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
Mechanical force regulates root resorption in rats through RANKL and OPG
Dysregulation of the RANKL/RANK/OPG axis in thalassemia intermedia patients